aica ribonucleotide has been researched along with B16 Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, MB; Gu, JH; Lu, PH; Shen, WX; Wu, XY; Yang, Y | 1 |
1 other study(ies) available for aica ribonucleotide and B16 Melanoma
Article | Year |
---|---|
Activation of AMP-activated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell.
Topics: Acetyl-CoA Carboxylase; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Mechanistic Target of Rapamycin Complex 1; Melanoma, Experimental; Mice; Multiprotein Complexes; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proteins; Pyrazoles; Pyrimidines; Reactive Oxygen Species; Ribonucleotides; RNA Interference; Time Factors; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53; Vincristine | 2011 |